vs
百富门（BF.B）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是百富门的1.4倍（$1.4B vs $1.0B），瑞思迈净利率更高（27.6% vs 21.6%，领先6.0%），瑞思迈同比增速更快（11.0% vs -5.4%），瑞思迈自由现金流更多（$311.2M vs $107.0M），过去两年瑞思迈的营收复合增速更高（9.0% vs -1.6%）
百富门（Brown-Forman）是美国家族控股上市企业，属全球规模最大的葡萄酒及烈酒经营集团之一，总部位于肯塔基州路易斯维尔。旗下拥有杰克丹尼、伍德福德珍藏、格兰多纳等多个国际知名酒类品牌，曾持有的南方安逸等品牌已于2016年出售。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
BF.B vs RMD — 直观对比
营收规模更大
RMD
是对方的1.4倍
$1.0B
营收增速更快
RMD
高出16.4%
-5.4%
净利率更高
RMD
高出6.0%
21.6%
自由现金流更多
RMD
多$204.2M
$107.0M
两年增速更快
RMD
近两年复合增速
-1.6%
损益表 — Q2 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.4B |
| 净利润 | $224.0M | $392.6M |
| 毛利率 | 59.4% | 61.8% |
| 营业利润率 | 29.4% | 34.6% |
| 净利率 | 21.6% | 27.6% |
| 营收同比 | -5.4% | 11.0% |
| 净利润同比 | -13.2% | 13.9% |
| 每股收益（稀释后） | $0.47 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BF.BRMD
| Q4 25 | $1.0B | $1.4B | ||
| Q3 25 | $924.0M | $1.3B | ||
| Q2 25 | $894.0M | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $951.0M | $1.2B | ||
| Q2 24 | $964.0M | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
净利润BF.BRMD
| Q4 25 | $224.0M | $392.6M | ||
| Q3 25 | $170.0M | $348.5M | ||
| Q2 25 | $146.0M | $379.7M | ||
| Q1 25 | $270.0M | $365.0M | ||
| Q4 24 | $258.0M | $344.6M | ||
| Q3 24 | $195.0M | $311.4M | ||
| Q2 24 | $266.0M | $292.2M | ||
| Q1 24 | $285.0M | $300.5M |
毛利率BF.BRMD
| Q4 25 | 59.4% | 61.8% | ||
| Q3 25 | 59.7% | 61.5% | ||
| Q2 25 | 57.4% | 60.8% | ||
| Q1 25 | 59.8% | 59.3% | ||
| Q4 24 | 59.0% | 58.6% | ||
| Q3 24 | 59.4% | 58.6% | ||
| Q2 24 | 59.0% | 58.5% | ||
| Q1 24 | 59.4% | 57.9% |
营业利润率BF.BRMD
| Q4 25 | 29.4% | 34.6% | ||
| Q3 25 | 28.1% | 33.4% | ||
| Q2 25 | 22.9% | 33.7% | ||
| Q1 25 | 27.1% | 33.0% | ||
| Q4 24 | 31.1% | 32.5% | ||
| Q3 24 | 29.5% | 31.6% | ||
| Q2 24 | 38.9% | 31.2% | ||
| Q1 24 | 34.9% | 31.3% |
净利率BF.BRMD
| Q4 25 | 21.6% | 27.6% | ||
| Q3 25 | 18.4% | 26.1% | ||
| Q2 25 | 16.3% | 28.2% | ||
| Q1 25 | 26.1% | 28.3% | ||
| Q4 24 | 23.6% | 26.9% | ||
| Q3 24 | 20.5% | 25.4% | ||
| Q2 24 | 27.6% | 23.9% | ||
| Q1 24 | 26.7% | 25.1% |
每股收益（稀释后）BF.BRMD
| Q4 25 | $0.47 | $2.68 | ||
| Q3 25 | $0.36 | $2.37 | ||
| Q2 25 | $0.31 | $2.58 | ||
| Q1 25 | $0.57 | $2.48 | ||
| Q4 24 | $0.55 | $2.34 | ||
| Q3 24 | $0.41 | $2.11 | ||
| Q2 24 | $0.56 | $1.97 | ||
| Q1 24 | $0.60 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $319.0M | $1.4B |
| 总债务越低越好 | $2.4B | $403.9M |
| 股东权益账面价值 | $4.1B | $6.3B |
| 总资产 | $8.2B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.59× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资BF.BRMD
| Q4 25 | $319.0M | $1.4B | ||
| Q3 25 | $471.0M | $1.4B | ||
| Q2 25 | $444.0M | $1.2B | ||
| Q1 25 | $599.0M | $932.7M | ||
| Q4 24 | $416.0M | $521.9M | ||
| Q3 24 | $416.0M | $426.4M | ||
| Q2 24 | $446.0M | $238.4M | ||
| Q1 24 | $589.0M | $237.9M |
总债务BF.BRMD
| Q4 25 | $2.4B | $403.9M | ||
| Q3 25 | $2.4B | $408.7M | ||
| Q2 25 | $2.4B | $658.4M | ||
| Q1 25 | $2.7B | $663.1M | ||
| Q4 24 | $2.7B | $662.9M | ||
| Q3 24 | $2.7B | $667.6M | ||
| Q2 24 | $2.7B | $697.3M | ||
| Q1 24 | $2.7B | $997.0M |
股东权益BF.BRMD
| Q4 25 | $4.1B | $6.3B | ||
| Q3 25 | $4.0B | $6.1B | ||
| Q2 25 | $4.0B | $6.0B | ||
| Q1 25 | $3.8B | $5.5B | ||
| Q4 24 | $3.7B | $5.3B | ||
| Q3 24 | $3.5B | $5.2B | ||
| Q2 24 | $3.5B | $4.9B | ||
| Q1 24 | $3.2B | $4.6B |
总资产BF.BRMD
| Q4 25 | $8.2B | $8.5B | ||
| Q3 25 | $8.2B | $8.3B | ||
| Q2 25 | $8.1B | $8.2B | ||
| Q1 25 | $8.1B | $7.6B | ||
| Q4 24 | $8.3B | $7.1B | ||
| Q3 24 | $8.2B | $7.2B | ||
| Q2 24 | $8.2B | $6.9B | ||
| Q1 24 | $8.2B | $6.8B |
负债/权益比BF.BRMD
| Q4 25 | 0.59× | 0.06× | ||
| Q3 25 | 0.61× | 0.07× | ||
| Q2 25 | 0.61× | 0.11× | ||
| Q1 25 | 0.70× | 0.12× | ||
| Q4 24 | 0.73× | 0.13× | ||
| Q3 24 | 0.77× | 0.13× | ||
| Q2 24 | 0.76× | 0.14× | ||
| Q1 24 | 0.83× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $132.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $107.0M | $311.2M |
| 自由现金流率自由现金流/营收 | 10.3% | 21.9% |
| 资本支出强度资本支出/营收 | 2.4% | 2.0% |
| 现金转化率经营现金流/净利润 | 0.59× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $610.0M | $1.8B |
8季度趋势，按日历期对齐
经营现金流BF.BRMD
| Q4 25 | $132.0M | $339.7M | ||
| Q3 25 | $160.0M | $457.3M | ||
| Q2 25 | $152.0M | $538.8M | ||
| Q1 25 | $317.0M | $578.7M | ||
| Q4 24 | $112.0M | $308.6M | ||
| Q3 24 | $17.0M | $325.5M | ||
| Q2 24 | $285.0M | $440.1M | ||
| Q1 24 | $265.0M | $402.0M |
自由现金流BF.BRMD
| Q4 25 | $107.0M | $311.2M | ||
| Q3 25 | $129.0M | $414.4M | ||
| Q2 25 | $102.0M | $508.2M | ||
| Q1 25 | $272.0M | $557.9M | ||
| Q4 24 | $81.0M | $288.0M | ||
| Q3 24 | $-24.0M | $307.7M | ||
| Q2 24 | $205.0M | $415.2M | ||
| Q1 24 | $196.0M | $380.8M |
自由现金流率BF.BRMD
| Q4 25 | 10.3% | 21.9% | ||
| Q3 25 | 14.0% | 31.0% | ||
| Q2 25 | 11.4% | 37.7% | ||
| Q1 25 | 26.3% | 43.2% | ||
| Q4 24 | 7.4% | 22.5% | ||
| Q3 24 | -2.5% | 25.1% | ||
| Q2 24 | 21.3% | 33.9% | ||
| Q1 24 | 18.3% | 31.8% |
资本支出强度BF.BRMD
| Q4 25 | 2.4% | 2.0% | ||
| Q3 25 | 3.4% | 3.2% | ||
| Q2 25 | 5.6% | 2.3% | ||
| Q1 25 | 4.3% | 1.6% | ||
| Q4 24 | 2.8% | 1.6% | ||
| Q3 24 | 4.3% | 1.5% | ||
| Q2 24 | 8.3% | 2.0% | ||
| Q1 24 | 6.5% | 1.8% |
现金转化率BF.BRMD
| Q4 25 | 0.59× | 0.87× | ||
| Q3 25 | 0.94× | 1.31× | ||
| Q2 25 | 1.04× | 1.42× | ||
| Q1 25 | 1.17× | 1.59× | ||
| Q4 24 | 0.43× | 0.90× | ||
| Q3 24 | 0.09× | 1.05× | ||
| Q2 24 | 1.07× | 1.51× | ||
| Q1 24 | 0.93× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BF.B
| Whiskey | $771.0M | 74% |
| Ready To Drink | $138.0M | 13% |
| Tequila | $67.0M | 6% |
| Restofportfolio | $52.0M | 5% |
| Nonbrandedandbulk | $8.0M | 1% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
